Jeff Del Carmen
Corporate Officer/Principal chez CATALYST PHARMACEUTICALS, INC.
Fortune : 413 930 $ au 31/03/2024
Profil
Jeff Del Carmen is currently the Chief Commercial Officer & Executive VP at Catalyst Pharmaceuticals, Inc. He previously worked as the Director-National Sales at Lundbeck, Inc. from 2011 to 2011, Senior Director-Rare Disease Marketing at Marathon Pharmaceuticals LLC from 2016 to 2017, and Vice President-Sales at INSYS Therapeutics, Inc. in 2016.
He also held the position of Vice President-Business Development at Paragon Biosciences LLC.
Mr. Del Carmen holds an MBA from the University of Wisconsin and an undergraduate degree from the University of Dayton.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/02/2024 | 25 968 ( 0,02% ) | 413 930 $ | 31/03/2024 |
Postes actifs de Jeff Del Carmen
| Sociétés | Poste | Début |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 23/06/2020 |
Anciens postes connus de Jeff Del Carmen
| Sociétés | Poste | Fin |
|---|---|---|
Marathon Pharmaceuticals LLC
 Marathon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Marathon Pharmaceuticals LLC is a holding company, which develops and manufactures pharmaceutical products. Its products include treatment for neurological disorders, rare cancers, and preanesthetics. The company was founded in 2008 and is headquartered in Northbrook, IL. | Corporate Officer/Principal | 01/07/2017 |
| INSYS THERAPEUTICS, INC. | Sales & Marketing | 01/07/2016 |
Lundbeck, Inc.
 Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The private company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | Sales & Marketing | 01/08/2011 |
Paragon Biosciences LLC
 Paragon Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Paragon Biosciences LLC is a life science innovator that creates, invests in, and builds life science companies in biopharmaceuticals, cell and gene therapy, and synthetic biology utilizing artificial intelligence. Paragon Biosciences is based in Chicago, IL, and has subsidiaries in the United States. The private company's current portfolio includes Castle Creek Biosciences, Circ Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences Holdings, Qlarity Imaging, Skyline Biosciences, and a consistent flow of incubating companies created and supported by the Paragon Innovation Capital™ model. The company's mission is to solve complex human and societal challenges by creating and supporting focused, visionary companies that accelerate the development of novel therapies and life science breakthroughs. The company was founded by Jeffrey S. Aronin, who has been the CEO since incorporation. | Corporate Officer/Principal | - |
Formation de Jeff Del Carmen
| University of Wisconsin | Masters Business Admin |
| University of Dayton | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Lundbeck, Inc.
Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The private company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | Health Technology |
INSYS Therapeutics, Inc.
 INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ. | Health Technology |
Marathon Pharmaceuticals LLC
Marathon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Marathon Pharmaceuticals LLC is a holding company, which develops and manufactures pharmaceutical products. Its products include treatment for neurological disorders, rare cancers, and preanesthetics. The company was founded in 2008 and is headquartered in Northbrook, IL. | Health Technology |
Paragon Biosciences LLC
Paragon Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Paragon Biosciences LLC is a life science innovator that creates, invests in, and builds life science companies in biopharmaceuticals, cell and gene therapy, and synthetic biology utilizing artificial intelligence. Paragon Biosciences is based in Chicago, IL, and has subsidiaries in the United States. The private company's current portfolio includes Castle Creek Biosciences, Circ Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences Holdings, Qlarity Imaging, Skyline Biosciences, and a consistent flow of incubating companies created and supported by the Paragon Innovation Capital™ model. The company's mission is to solve complex human and societal challenges by creating and supporting focused, visionary companies that accelerate the development of novel therapies and life science breakthroughs. The company was founded by Jeffrey S. Aronin, who has been the CEO since incorporation. | Commercial Services |
